- Home
- CLPT vs TRML Comparison
CLPT vs TRML Comparison
Compare CLPT & TRML Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLPT
- TRML
- Stock Information
- Founded
- CLPT 1998
- TRML 2021
- Country
- CLPT United States
- TRML United States
- Employees
- CLPT N/A
- TRML N/A
- Industry
- CLPT Medical/Dental Instruments
- TRML Biotechnology: Pharmaceutical Preparations
- Sector
- CLPT Health Care
- TRML Health Care
- Exchange
- CLPT Nasdaq
- TRML Nasdaq
- Market Cap
- CLPT 355.7M
- TRML 419.1M
- IPO Year
- CLPT N/A
- TRML N/A
- Fundamental
- Price
- CLPT $12.14
- TRML $29.21
- Analyst Decision
- CLPT Strong Buy
- TRML Strong Buy
- Analyst Count
- CLPT 2
- TRML 3
- Target Price
- CLPT $12.00
- TRML $64.67
- AVG Volume (30 Days)
- CLPT 237.3K
- TRML 202.3K
- Earning Date
- CLPT 11-07-2024
- TRML 11-07-2024
- Dividend Yield
- CLPT N/A
- TRML N/A
- EPS Growth
- CLPT N/A
- TRML N/A
- EPS
- CLPT N/A
- TRML N/A
- Revenue
- CLPT $28,069,000.00
- TRML N/A
- Revenue This Year
- CLPT $33.39
- TRML N/A
- Revenue Next Year
- CLPT $24.44
- TRML N/A
- P/E Ratio
- CLPT N/A
- TRML N/A
- Revenue Growth
- CLPT 29.33
- TRML N/A
- 52 Week Low
- CLPT $4.05
- TRML $12.12
- 52 Week High
- CLPT $14.13
- TRML $48.31
- Technical
- Relative Strength Index (RSI)
- CLPT 41.22
- TRML 58.78
- Support Level
- CLPT $12.39
- TRML $25.10
- Resistance Level
- CLPT $13.86
- TRML $28.35
- Average True Range (ATR)
- CLPT 0.87
- TRML 1.37
- MACD
- CLPT -0.10
- TRML -0.26
- Stochastic Oscillator
- CLPT 33.57
- TRML 57.98
About CLPT ClearPoint Neuro Inc.
ClearPoint Neuro Inc is a medical device company based in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain and heart under direct, intra-procedural magnetic resonance imaging (MRI) guidance. The company's ClearPoint system, which is in commercial use, is used to perform minimally invasive surgical procedures in the brain. The company's products include the ClearPoint system, ClearPoint Services, and ClearPoint Therapeutic Solutions.
About TRML Tourmaline Bio Inc.
Tourmaline Bio Inc is a late-stage clinical biotechnology company driven by its mission to develop transformative medicines that dramatically improve the lives of patients with life-altering immune diseases. Its initial product candidate is TOUR006, a fully human monoclonal antibody that selectively binds to interleukin-6 (IL-6), a key proinflammatory cytokine involved in the pathogenesis of many autoimmune and inflammatory disorders. The anti-IL-6 and anti-IL-6 receptor (IL-6R) antibody class (IL-6 class) has over two decades of clinical and commercial experience treating over a million patients with a variety of autoimmune and inflammatory diseases.